Betaseron (Chiron Corp)
Betaseron (Chiron Corp) Brand names, Betaseron (Chiron Corp) Analogs
Betaseron (Chiron Corp) Brand Names Mixture
- No information avaliable
Betaseron (Chiron Corp) Chemical_Formula
C908H1408N246O253S6
Betaseron (Chiron Corp) RX_link
http://www.rxlist.com/cgi/generic/interferon_beta.htm
Betaseron (Chiron Corp) fda sheet
Betaseron (Chiron Corp) msds (material safety sheet)
Betaseron (Chiron Corp) Synthesis Reference
No information avaliable
Betaseron (Chiron Corp) Molecular Weight
20011.0
Betaseron (Chiron Corp) Melting Point
No information avaliable
Betaseron (Chiron Corp) H2O Solubility
No information avaliable
Betaseron (Chiron Corp) State
Liquid
Betaseron (Chiron Corp) LogP
-0.447
Betaseron (Chiron Corp) Dosage Forms
Solution (Subcutaneous Injection); Powder for solution
Betaseron (Chiron Corp) Indication
For treatment of relapsing/remitting multiple sclerosis
Betaseron (Chiron Corp) Pharmacology
Interferon beta upregulates the expression of MHC I proteins, allowing for increased presentation of peptides derived from viral antigens. This enhances the activation of CD8+ T cells that are the precursors for cytotoxic T lymphocytes (CTLs) and makes the macrophage a better target for CTL-mediated killing. Type I interferons also induce the synthesis of several key antiviral mediators including 2'-5' oligoadenylate synthetase (2'-5' A synthetase), beta-2 microglobulin, neopterin and protein kinase R.
Betaseron (Chiron Corp) Absorption
No information avaliable
Betaseron (Chiron Corp) side effects and Toxicity
No information avaliable
Betaseron (Chiron Corp) Patient Information
BIOD00078.html
Betaseron (Chiron Corp) Organisms Affected
No information avaliable
